Tower Research Capital (TRC)’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-817
| Closed | -$5K | – | 4446 |
|
|
2019
Q4 | $5K | Sell |
817
-3,372
| -80% | -$20.6K | ﹤0.01% | 2737 |
|
|
2019
Q3 | $15K | Sell |
4,189
-4,648
| -53% | -$16.6K | ﹤0.01% | 2705 |
|
|
2019
Q2 | $24K | Buy |
+8,837
| New | +$24K | ﹤0.01% | 2070 |
|
|
2018
Q4 | – | Sell |
-4,437
| Closed | -$16K | – | 4659 |
|
|
2018
Q3 | $16K | Buy |
+4,437
| New | +$16K | ﹤0.01% | 2504 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4232 |
|
|
2017
Q4 | – | Sell |
-10,659
| Closed | -$48K | – | 4424 |
|
|
2017
Q3 | $48K | Buy |
+10,659
| New | +$48K | ﹤0.01% | 2028 |
|
|
2017
Q1 | – | Sell |
-2,291
| Closed | -$9K | – | 4331 |
|
|
2016
Q4 | $9K | Buy |
2,291
+2,191
| +2,191% | +$8.61K | ﹤0.01% | 2740 |
|
|
2016
Q3 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 3446 |
|
|
2016
Q2 | – | Sell |
-1,107
| Closed | -$9K | – | 5288 |
|
|
2016
Q1 | $9K | Buy |
+1,107
| New | +$9K | ﹤0.01% | 2118 |
|
|
2015
Q3 | – | Sell |
-9,610
| Closed | -$85K | – | 5202 |
|
|
2015
Q2 | $85K | Sell |
9,610
-7,086
| -42% | -$62.7K | 0.01% | 980 |
|
|
2015
Q1 | $165K | Buy |
16,696
+15,742
| +1,650% | +$156K | 0.02% | 529 |
|
|
2014
Q4 | $12K | Sell |
954
-4,368
| -82% | -$54.9K | ﹤0.01% | 2021 |
|
|
2014
Q3 | $53K | Buy |
+5,322
| New | +$53K | 0.01% | 1484 |
|
|
2014
Q1 | – | Sell |
-17,839
| Closed | -$59K | – | 5216 |
|
|
2013
Q4 | $59K | Buy |
+17,839
| New | +$59K | 0.01% | 1258 |
|
|
2013
Q3 | – | Sell |
-4,361
| Closed | -$36K | – | 4989 |
|
|
2013
Q2 | $36K | Buy |
+4,361
| New | +$36K | ﹤0.01% | 1200 |
|